Aurora Cannabis (ACB) FCF Margin (2017 - 2026)
Aurora Cannabis (ACB) posted quarterly FCF Margin of 2.84% for Q1 2026, up 2091.0% year-on-year from 0.13% in Q1 2025, and down 88.26% on a QoQ basis from 24.24% in Q4 2025.
Aurora Cannabis (ACB) FCF Margin (2017 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported FCF Margin for 10 consecutive years, with 2.84% the latest figure, recorded in Q1 2026.
- Quarterly FCF Margin rose 2091.0% year-over-year to 2.84% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 7.4% (up 580.0% YoY) and the FY2026 annual result came in at 9.47%, down 1339.0% from the prior year.
- FCF Margin declined to 2.84% in Q1 2026 per ACB's latest filing, from 24.24% in the prior quarter.
- Over the last five years, FCF Margin for ACB reached as high as 38.21% in Q4 2024 and fell as low as 73.02% in Q1 2024.
- A 5-year average of 20.02% and a median of 11.56% in 2024 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2022 — FCF Margin tumbled 8137 bps — and 2023, when it soared 6264 bps.
- Year by year, FCF Margin stood at 66.5% in 2022, then surged by 94 bps to 3.86% in 2023, then soared by 1089 bps to 38.21% in 2024, then sank by 37 bps to 24.24% in 2025, then sank by 88 bps to 2.84% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 2.84%, 24.24%, and 18.06% for Q1 2026, Q4 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -5.22% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 12.86% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5.35% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 46.54% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 9.93% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 17.73% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.77% |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | 2.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.84% |
| Dec 31, 2025 | 24.24% |
| Mar 31, 2025 | -18.06% |
| Dec 31, 2024 | 38.21% |
| Sep 30, 2024 | -11.56% |
| Jun 30, 2024 | 6.10% |
| Mar 31, 2024 | -73.02% |
| Dec 31, 2023 | -3.86% |
| Sep 30, 2023 | -4.75% |
| Dec 31, 2022 | -66.50% |
| Sep 30, 2022 | -47.81% |
| Jun 30, 2022 | -41.39% |
| Mar 31, 2022 | -64.71% |
| Dec 31, 2021 | -3.02% |
| Sep 30, 2021 | -42.56% |
| Jun 30, 2021 | 39.99% |
| Mar 31, 2021 | -81.88% |
| Dec 31, 2020 | -74.25% |
| Sep 30, 2020 | -136.79% |
| Jun 30, 2020 | -18.73% |